Background: There are an estimated 1.6 million people living with a limb amputation in the U.S. Approximately 50-80% of amputees suffer phantom limb pain (PLP), which is pain felt in the absence of a limb that may manifest as stabbing, burning, throbbing or in some other fashion. Mirror therapy has been proposed as an alternative therapy for the treatment of PLP, but its efficacy as an interven...

BACKGROUND AND OBJECTIVE Since the beginning of the conflicts in Iraq and Afghanistan, there has been a dramatic increase in the number of military service members with single and multiple-limb amputations. Phantom limb pain (PLP) frequently develops in these individuals. As a result, identifying the best methods to treat PLP is critical. The review highlights areas of inquiry related to phanto...

Psychophysiological assessments and biofeedback based interventions for disorders whose main symptom of interest is chronic pain can be highly effective and useful in the clinical environment. The evidence supporting the effectiveness of psychophysiological assessments and interventions for phantom limb pain, upper and lower back pain, non-cardiac chest pain, and pelvic floor pain disorders is ...

Psychophysiological assessments and biofeedback based interventions for disorders whose main symptom of interest is chronic pain can be highly effective and useful in the clinical environment. The evidence supporting the effectiveness of psychophysiological assessments and interventions for phantom limb pain, upper and lower back pain, non-cardiac chest pain, and pelvic floor pain disorders is ...

PURPOSE: Regenerative Peripheral Nerve Interfaces (RPNIs) can be used to treat symptomatic end neuromas that develop after major limb amputation. Symptomatic neuromas occur in approximately 30–40% of individuals after limb loss and phantom limb pain affects 70–95% of these patients. We investigate the potential of prophylactic RPNIs to prevent neuroma formation and to mitigate the experience of...

PURPOSE: Regenerative Peripheral Nerve Interfaces (RPNIs) can be used to treat symptomatic end neuromas that develop after major limb amputation. Symptomatic neuromas occur in approximately 30–40% of individuals after limb loss and phantom limb pain affects 70–95% of these patients. We investigate the potential of prophylactic RPNIs to prevent neuroma formation and to mitigate the experience of...